市場調査レポート
商品コード
1370564

哺乳類ポリクローナルIgG抗体市場:世界の産業動向、シェア、市場規模、成長、機会、2023-2028年予測

Mammalian Polyclonal IgG Antibody Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 145 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
哺乳類ポリクローナルIgG抗体市場:世界の産業動向、シェア、市場規模、成長、機会、2023-2028年予測
出版日: 2023年10月15日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

市場概要:

世界の哺乳類ポリクローナルIgG抗体市場規模は、2022年に10億3,820万米ドルに達しました。今後、IMARC Groupは、市場は2023年から2028年の間に5.2%の成長率(CAGR)を示し、2028年までに14億1,530万米ドルに達すると予測しています。

哺乳類ポリクローナル免疫グロブリン(IgG)抗体は、マウス、ウサギ、ヤギなど様々な哺乳類に接種して製造される抗原または予防接種を指します。この方法では、IgGを供給するBリンパ球を活性化させるために、哺乳動物の体内に抗原を注射で投与します。これらの抗体は、酵素結合免疫吸着測定法(ELISA)、ウェスタンブロット試験、免疫放射測定法(IRMA)、ラジオイムノアッセイ(RIA)など、複数の免疫測定試験における標識試薬に使用されます。これとは別に、このプロセスは熟練した専門家を必要とせず、大量の予防接種を製造することができます。哺乳類ポリクローナルIgG抗体は、複数の治療薬の作製、様々な病気の診断、抗体の同定やフローサイトメトリーの実施に役立ちます。その結果、変性タンパク質を検出したり、病気やその治療法を調べたりする生化学研究に幅広く応用されています。現在、心臓マーカー、代謝マーカー、腎マーカーの製品バリエーションが市販されています。

哺乳類ポリクローナルIgG抗体の市場動向:

がんや自己免疫疾患を含む様々な慢性疾患の有病率の増加や、研究環境における複数の免疫測定試験や治療・分析用途の抗体に対するニーズの高まりが、主に市場成長の原動力となっています。これに伴い、先進技術による効果的な新規予防接種や注射剤の製剤化のために、政府がバイオテクノロジーや製薬会社に多額の投資を行っていることも、成長を促す要因となっています。さらに、バイオ製薬企業が品質管理(QC)のために独創的な哺乳類抗体を開発し続けていることも、市場の成長に寄与しています。さらに、B細胞リンパ腫と白血病の正確かつ迅速な診断のために、バイオマーカーの承認が進み、臨床医によって幅広く使用されていることも、市場の成長を支えています。これとは別に、医療インフラの大幅な強化や抗体の有効性を高めるための研究開発(R&D)活動が、市場に明るい展望をもたらしています。

本レポートで扱う主な質問

  • 世界の哺乳類ポリクローナルIgG抗体市場の規模は?
  • 2023-2028年の世界の哺乳類ポリクローナルIgG抗体市場の予想成長率は?
  • 世界の哺乳類ポリクローナルIgG抗体市場を牽引する主要因は?
  • COVID-19が世界の哺乳類ポリクローナルIgG抗体市場に与えた影響は?
  • 世界の哺乳類ポリクローナルIgG抗体市場のタイプ別区分は?
  • 哺乳類ポリクローナルIgG抗体の世界市場における製品別の区分は?
  • 哺乳類ポリクローナルIgG抗体の世界市場の用途別区分は?
  • 哺乳類ポリクローナルIgG抗体の世界市場のエンドユースに基づく区分は?
  • 哺乳類ポリクローナルIgG抗体の世界市場における主要地域は?
  • 世界の哺乳類ポリクローナルIgG抗体市場における主要プレイヤー/企業は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の哺乳類ポリクローナルIgG抗体市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:タイプ別

  • ヤギ
    • 市場動向
    • 市場予測
  • ウサギ
    • 市場動向
    • 市場予測
  • ウマ
    • 市場動向
    • 市場予測
  • マウス
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳:製品別

  • 心臓マーカー
    • 市場動向
    • 市場予測
  • 代謝マーカー
    • 市場動向
    • 市場予測
  • 腎臓マーカー
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳:用途別

  • ELISA
    • 市場動向
    • 市場予測
  • 免疫比濁法
    • 市場動向
    • 市場予測
  • 免疫電気泳動
    • 市場動向
    • 市場予測
  • 抗体同定
    • 市場動向
    • 市場予測
  • 免疫組織化学
    • 市場動向
    • 市場予測
  • 免疫細胞化学
    • 市場動向
    • 市場予測
  • ウェスタンブロッティング
    • 市場動向
    • 市場予測

第9章 市場内訳:最終用途別

  • 病院
    • 市場動向
    • 市場予測
  • 診断センター
    • 市場動向
    • 市場予測
  • 学術・研究機関
    • 市場動向
    • 市場予測

第10章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbiotec Inc.
    • Abcam plc
    • Bio-Rad Laboratories Inc.
    • Cell Signaling Technology Inc.
    • Creative Diagnostics
    • Elabscience Biotechnology Inc.
    • Geno Technology Inc.
    • Merck KGaA
    • Proteintech Group Inc.
    • STEMCELL Technologies Inc.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Mammalian Polyclonal IgG Antibody Market: Major Drivers and Challenges
  • Figure 2: Global: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by Product (in %), 2022
  • Figure 6: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by End Use (in %), 2022
  • Figure 8: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Mammalian Polyclonal IgG Antibody (Goat) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Mammalian Polyclonal IgG Antibody (Goat) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Mammalian Polyclonal IgG Antibody (Rabbit) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Mammalian Polyclonal IgG Antibody (Rabbit) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Mammalian Polyclonal IgG Antibody (Horse) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Mammalian Polyclonal IgG Antibody (Horse) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Mammalian Polyclonal IgG Antibody (Mouse) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Mammalian Polyclonal IgG Antibody (Mouse) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Mammalian Polyclonal IgG Antibody (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Mammalian Polyclonal IgG Antibody (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Mammalian Polyclonal IgG Antibody (Cardiac Markers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Mammalian Polyclonal IgG Antibody (Cardiac Markers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Mammalian Polyclonal IgG Antibody (Metabolic Markers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Mammalian Polyclonal IgG Antibody (Metabolic Markers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Mammalian Polyclonal IgG Antibody (Renal Markers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Mammalian Polyclonal IgG Antibody (Renal Markers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Mammalian Polyclonal IgG Antibody (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Mammalian Polyclonal IgG Antibody (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Mammalian Polyclonal IgG Antibody (ELISA) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Mammalian Polyclonal IgG Antibody (ELISA) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Mammalian Polyclonal IgG Antibody (Immunoturbidimetry) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Mammalian Polyclonal IgG Antibody (Immunoturbidimetry) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Mammalian Polyclonal IgG Antibody (Immunoelectrophoresis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Mammalian Polyclonal IgG Antibody (Immunoelectrophoresis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Mammalian Polyclonal IgG Antibody (Antibody Identification) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Mammalian Polyclonal IgG Antibody (Antibody Identification) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Mammalian Polyclonal IgG Antibody (Immunohistochemistry) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Mammalian Polyclonal IgG Antibody (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Mammalian Polyclonal IgG Antibody (Immunocytochemistry) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Mammalian Polyclonal IgG Antibody (Immunocytochemistry) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Mammalian Polyclonal IgG Antibody (Western Blotting) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Mammalian Polyclonal IgG Antibody (Western Blotting) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Mammalian Polyclonal IgG Antibody (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Mammalian Polyclonal IgG Antibody (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Mammalian Polyclonal IgG Antibody (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Mammalian Polyclonal IgG Antibody (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Global: Mammalian Polyclonal IgG Antibody (Academic and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Global: Mammalian Polyclonal IgG Antibody (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: North America: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: North America: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: United States: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: United States: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Canada: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Canada: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Asia-Pacific: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Asia-Pacific: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: China: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: China: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Japan: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Japan: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: India: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: India: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: South Korea: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: South Korea: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Australia: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Australia: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Indonesia: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Indonesia: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Others: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Others: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Europe: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Europe: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Germany: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Germany: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: France: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: France: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: United Kingdom: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: United Kingdom: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Italy: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Italy: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Spain: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Spain: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Russia: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Russia: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Others: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Others: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Latin America: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Latin America: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Brazil: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Brazil: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Mexico: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Mexico: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Others: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Others: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Middle East and Africa: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 94: Middle East and Africa: Mammalian Polyclonal IgG Antibody Market: Breakup by Country (in %), 2022
  • Figure 95: Middle East and Africa: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 96: Global: Mammalian Polyclonal IgG Antibody Industry: SWOT Analysis
  • Figure 97: Global: Mammalian Polyclonal IgG Antibody Industry: Value Chain Analysis
  • Figure 98: Global: Mammalian Polyclonal IgG Antibody Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Mammalian Polyclonal IgG Antibody Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 6: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Mammalian Polyclonal IgG Antibody Market: Competitive Structure
  • Table 8: Global: Mammalian Polyclonal IgG Antibody Market: Key Players
目次
Product Code: SR112023A6464

Abstract

Market Overview:

The global mammalian polyclonal IgG antibody market size reached US$ 1,038.2 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,415.3 Million by 2028, exhibiting a growth rate (CAGR) of 5.2% during 2023-2028.

Mammalian polyclonal immunoglobulins (IgG) antibody refers to antigens or vaccinations that are manufactured through inoculation of various mammals, including mice, rabbits, and goats. During this procedure, an antigen is administered via injectable into the mammal body to activate the B-lymphocytes that supply IgG. These antibodies are used in labeling reagents in multiple immunoassay tests, including enzyme-linked immunosorbent assay (ELISA), western blot tests, immunoradiometric assay (IRMA), and radioimmunoassay (RIA). Apart from this, the process does not require skilled professionals to produce large batches of vaccinations. Mammalian polyclonal IgG antibody helps create multiple therapeutics, diagnose various ailments, and perform antibody identification and flow cytometry. As a result, they find extensive applications in biochemical research to detect denatured proteins and examine diseases and their treatments. At present, they are commercially available in cardiac, metabolic, and renal marker product variants.

Mammalian Polyclonal IgG Antibody Market Trends:

The increasing prevalence of various chronic disorders, including cancer and autoimmune ailments, and the rising need for antibodies for multiple immunoassay tests and therapeutic and analytical applications in research settings are primarily driving the market growth. In line with this, significant investments in biotechnology and pharmaceutical companies by governments to formulate effective novel vaccinations and injectables through advanced technologies are acting as another growth-inducing factor. Additionally, the ongoing innovation of creative mammalian antibodies by biopharma organizations for quality control (QC) is contributing to the market growth. Moreover, the escalating biomarkers approval and their extensive usage by clinicians for accurate and rapid diagnosis of B-cell lymphoma and leukemia are supporting the market growth. Apart from this, significant enhancements in the healthcare infrastructure and research and development (R&D) activities to enhance antibody efficacy are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global mammalian polyclonal IgG antibody market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, product, application and end use.

Breakup by Type:

Goat

Rabbit

Horse

Mouse

Others

Breakup by Product:

Cardiac Markers

Metabolic Markers

Renal Markers

Others

Breakup by Application:

ELISA

Immunoturbidimetry

Immunoelectrophoresis

Antibody Identification

Immunohistochemistry

Immunocytochemistry

Western Blotting

Breakup by End Use:

Hospitals

Diagnostic Centers

Academic and Research Institutes

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbiotec Inc., Abcam plc, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Creative Diagnostics, Elabscience Biotechnology Inc., Geno Technology Inc., Merck KGaA, Proteintech Group Inc., STEMCELL Technologies Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. How big is the global mammalian polyclonal IgG antibody market?
  • 2. What is the expected growth rate of the global mammalian polyclonal IgG antibody market during 2023-2028?
  • 3. What are the key factors driving the global mammalian polyclonal IgG antibody market?
  • 4. What has been the impact of COVID-19 on the global mammalian polyclonal IgG antibody market?
  • 5. What is the breakup of the global mammalian polyclonal IgG antibody market based on the type?
  • 6. What is the breakup of the global mammalian polyclonal IgG antibody market based on the product?
  • 7. What is the breakup of the global mammalian polyclonal IgG antibody market based on the application?
  • 8. What is the breakup of the global mammalian polyclonal IgG antibody market based on the end use?
  • 9. What are the key regions in the global mammalian polyclonal IgG antibody market?
  • 10. Who are the key players/companies in the global mammalian polyclonal IgG antibody market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Mammalian Polyclonal IgG Antibody Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Goat
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Rabbit
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Horse
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Mouse
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Cardiac Markers
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Metabolic Markers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Renal Markers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 ELISA
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Immunoturbidimetry
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Immunoelectrophoresis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Antibody Identification
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Immunohistochemistry
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Immunocytochemistry
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Western Blotting
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by End Use

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic and Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbiotec Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Abcam plc
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bio-Rad Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Cell Signaling Technology Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Creative Diagnostics
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Elabscience Biotechnology Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Geno Technology Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Merck KGaA
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Proteintech Group Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 STEMCELL Technologies Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis